Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: corticosteroids

Dermatology Patients on Corticosteroids May Not Receive Osteoporosis Screenings; Plus FDA Approves ZTLido

Michele B. Kaufman, PharmD, BCGP  |  March 28, 2018

A recent study found that dermatology patients taking long-term steroids are not always evaluated for steroid-induced osteoporosis…

Filed under:AnalgesicsConditionsDrug UpdatesOsteoarthritis and Bone Disorders Tagged with:CorticosteroidsDermatologyFDAOsteoporosisPainSteroidsU.S. Food and Drug Administration (FDA)ZTLido

Why Oral Corticosteroids Should Not be Used in Patients with Rheumatoid Arthritis

Anthony S. Russell, MA, MB, BCHIR  |  April 1, 2013

 Steroid use in patients with rheumatoid arthritis (RA) has been linked to higher mortality rates, greater rate of infections, more cases of pneumonia, and serious gastrointestinal events

Filed under:ConditionsDrug UpdatesRheumatoid Arthritis Tagged with:Oral CorticosteroidsRARheumatoid arthritisSteroid

The Great Imitator: Updates on Sarcoidosis

Jason Liebowitz, MD, FACR  |  January 15, 2025

Michelle Sharp, MD, MHS, shared insights into the complexities of sarcoidosis, describing how she evaluates, diagnoses and treats patients.

Filed under:ConditionsEULAR/OtherMeeting ReportsOther Rheumatic Conditions Tagged with:neurosarcoidosispatient carepulmonary sarcoidosisSarcoidosis

Skin Matters: The Intersection of Dermatology & Rheumatology

Jason Liebowitz, MD, FACR  |  January 1, 2025

Jun Kang, MD, addressed the intersection of dermatology and rheumatology, describing the nuance necessary to accurately evaluate skin manifestations and differentiate multiple conditions.

Filed under:ConditionsEULAR/OtherMeeting ReportsMyositisSystemic Lupus Erythematosus Tagged with:cutaneous lupus erythematosus (CLE)Dermatologydermatomyositisneutrophilic dermatosesskinskin disease

ACR Image Competition 2024 Results, Part 1—Best Overall

Rachel Guess, MD  |  December 10, 2024

For the 2024 Image Competition, the ACR sought images representing a diverse range of patients with educational or remarkable manifestations of pediatric rheumatic diseases, including autoimmune, inflammatory, infectious and malignant drivers of pediatric rheumatic disease. Here, we showcase the images selected as Best Overall. Cavitary Lung Nodules with Sinus & Skin Disease in Pediatric ANCA-Associated…

Filed under:ConditionsVasculitis Tagged with:ANCA-Associated Vasculitisimage case reportImage CompetitionPediatric

Case Report: Uncommon Complications in ANCA-Associated Vasculitis

Logan Oliver, MD, & Jason J. Weiner, MD, FACP, FACR  |  December 9, 2024

Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis is a rare autoimmune condition characterized by inflammation of small- and medium-sized vessels. ANCA-associated vasculitis can lead to multisystem organ complications, including life-threatening pulmonary hemorrhage, renal failure and death. We present a case of ANCA-associated vasculitis complicated by complement-mediated thrombotic microangiopathy (c-TMA). Of the rheumatic diseases, systemic lupus erythematosus…

Filed under:ConditionsVasculitis Tagged with:ANCA-Associated Vasculitisc-TMAcase reportcomplement-mediated thrombotic microangiopathy (c-TMA)Fellows Forum

MCTD: Is It Just Letters?

Ruth Jessen Hickman, MD  |  December 4, 2024

At a Great Debate session, speakers discussed whether mixed connective tissue disease is a distinct disease entity in rheumatology.

Filed under:ACR ConvergenceConditionsGuidanceMeeting ReportsOther Rheumatic Conditions Tagged with:ACR Convergence 2024connective tissue diseasemixed connective tissue disease (MCTD)

Top Research in Rheumatoid Arthritis Presented at ACR Convergence 2024

Jeffrey Curtis, MD, MS, MPH  |  December 3, 2024

Why this research is relevant to clinicians today & researchers in the future WASHINGTON, D.C.—The ACR Convergence 2024 meeting in Washington, D.C., reflected the continued advancement of science and practical research in the field of rheumatoid arthritis. Highlights this year centered on new RA treatments and new uses of existing treatments; the use of artificial…

Filed under:ACR ConvergenceConditionsGuidanceMeeting ReportsRheumatoid Arthritis Tagged with:ACR Convergence 2024ACR Convergence 2024 RA

Systemic Lupus Erythematosus: A Complex, Multi-Challenging Disease

Graciela S. Alarcón, MD, MPH, MACR  |  November 26, 2024

Reviewing the research presented at ACR Convergence 2024.

Filed under:ACR ConvergenceConditionsGuidanceMeeting ReportsProfessional TopicsResearch ReviewsResearch RheumSystemic Lupus Erythematosus Tagged with:ACR Convergence 2024ACR Convergence 2024 SLE

Can Cultural Humility Conquer Systemic Inequity in Pediatric Rheumatology?

Glen Rodman  |  November 26, 2024

Doctors and patient advocates urged the rheumatology community to address the drastic inadequacies in care faced by marginalized people in a session held at ACR Convergence 2024.

Filed under:ACR ConvergenceLegislation & AdvocacyMeeting ReportsMeeting ReportsPatient PerspectivePediatric ConditionsSystemic Lupus Erythematosus Tagged with:ACR Convergence 2024Equitypatient advocacyPediatric

  • 1
  • 2
  • 3
  • …
  • 44
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences